
External Beam Radiotherapy in India
EBRT in India is named after the target, previous dose and organ constraints, not a linac brochure. GAF planning is $1,000–$6,000+, typically 15–35 sessions over 4–7 weeks.
Curated treatment library
Explore patient-focused treatment guides and connect with experienced care teams across trusted international destinations.
93 treatments found

EBRT in India is named after the target, previous dose and organ constraints, not a linac brochure. GAF planning is $1,000–$6,000+, typically 15–35 sessions over 4–7 weeks.

IMRT in India is named after target geometry and organ constraints, not a linac brochure. GAF planning is $6,500–$14,500, typically 4–7 weeks of fractions.

IGRT in India is named after motion, margins and the imaging protocol, not a linac brochure. GAF planning is $7,200–$16,000, typically 4–7 weeks of fractions.

SRS in India is named after lesion volume, location and previous dose, not a machine brochure. GAF planning is $8,500–$18,000, typically 1–5 sessions.

SBRT in India is named after tumour site, size, motion and previous dose, not a machine brochure. GAF planning is $8,000–$17,500, typically 1–5 sessions.

CyberKnife in India is a robotic platform that can deliver named SRS or SBRT, not a machine brochure. GAF planning is $11,000–$24,000, typically 1–5 sessions.

Gamma Knife in India is a dedicated intracranial radiosurgery platform that can deliver named SRS, not a machine brochure. GAF planning is $10,500–$22,000, typically 1 session.

Proton beam therapy in India is a named Bragg-peak external-beam product, not a machine brochure. GAF planning is $28,000–$55,000, typically 4–8 weeks of fractions.

Brachytherapy in India is a named internal-radiation implant product, not a machine brochure. GAF planning is $5,500–$13,000, typically 1–7 nights.

Dendritic cell therapy in India is a named autologous vaccine product, not a brochure immune boost. GAF planning is $8,000–$22,000, typically leukapheresis plus staged infusions.

Intrathecal chemotherapy in India delivers selected anticancer medicine into CSF. GAF planning is $3,000–$10,000, typically day-care LP or Ommaya access.

Intraperitoneal chemotherapy in India delivers selected anticancer medicine into the abdominal cavity. GAF planning is $5,000–$14,000, typically tied to cytoreduction or IP ports.

Adjuvant chemotherapy in India is systemic treatment after primary cancer therapy, usually surgery. GAF planning is $2,500–$10,000, typically cycles after surgery over 3–6 months.

Neoadjuvant chemotherapy in India is systemic treatment before planned surgery. GAF planning is $2,500–$10,000, typically cycles before surgery over 2–4 months.

Molecular targeted therapy in India matches cancer medicines to documented tumour alterations. GAF planning is $10,000–$32,000, typically oral or infusion by mutation.

Precision oncology in India uses genomic and biomarker testing to match cancer care. GAF planning is $2,000–$7,000, typically an NGS panel plus clinic visit.

Hormone therapy in India for hormone-sensitive cancers. GAF planning is $1,000–$4,500, typically outpatient tablets over years.

Targeted therapy in India matches medicines to tumour biomarkers. GAF planning is $8,000–$30,000, typically oral or infusion over months.